Загрузка...
Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD
T‐cell acute lymphoblastic leukemia (T‐ALL) and T‐cell lymphoblastic lymphoma (T‐LBL) are neoplasms that originate from T‐cell precursors. Outcomes in adult patients with T‐ALL/LBL remain unsatisfactory; early relapse following intensive induction chemotherapy is a concern, and patients with relapse...
Сохранить в:
| Опубликовано в: : | Hematol Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5836898/ https://ncbi.nlm.nih.gov/pubmed/28560733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hon.2421 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|